Opinion | Make HHS and FDA Pro-Life Again
NegativeU.S News

The recent approval of generic mifepristone has sparked significant concern among pro-life advocates, particularly in light of warnings regarding RFK Jr.'s potential influence in health policy. This decision is seen as a setback for those who oppose abortion, highlighting the ongoing debate over reproductive rights and the role of government agencies in these matters.
— Curated by the World Pulse Now AI Editorial System